Fresenius Medical Care AG (FMS) Form 6-K — Nov 3, 2026
Fresenius Medical Care reported Q3 2026 revenue of EUR 4,937 million, up 1% year over year, but reported operating income fell 19% to EUR 384 million and net income dropped 42% to EUR 160 million, driven mainly by EUR 108 million in one-time costs from refining its China strategy. The company narrowed its FY2026 outlook to the lower half: revenue broadly flat and operating income growth between flat and a negative mid-single digit percent, citing TDAPA reimbursement headwinds and inflation. New CEO Shervin J. Korangy, three weeks into the role, pledged 'transformational improvements in performance' beyond incremental gains.
Key figures
- Eps
- 0.61
- Eps Beat
- 0
- Revenue
- 4937000000
- Guidance
- FY2026 revenue broadly flat; operating income growth narrowed to between flat and a negative mid-single digit percent vs 2025 base of EUR 2,212 million
- Net Income
- 160000000
- Revenue Yoy
- +1% (+0.1% organic, -1% at constant currency)
- Clinics
- 3512
- Employees
- 106291
- Ebitda q3 eur m
- 817
- 5008x us clinics
- 348
- Patients treated
- 289014
- 5008x treatments m
- 1.3
- Net leverage ratio
- 2.6
- Buyback pct of shares
- 3.4
- Net income change pct
- -42
- Fme25 savings 9m eur m
- 74
- Free cash flow 9m eur m
- 1229
- Free cash flow q3 eur m
- 564
- Buyback investment eur m
- 357
- Basic eps ex specials eur
- 1.11
- China onetime costs eur m
- 108
- Net debt and leases eur m
- 9787
- Operating income q3 eur m
- 384
- Buyback program volume eur
- 1000000000
- Buyback shares repurchased m
- 9.1
- Operating cash flow q3 eur m
- 798
- Operating income q3 change pct
- -19
- Fme25 savings target 2026 eur m
- 250
- Fme25 savings target 2027 eur m
- 1200
- Us same market treatment growth pct
- -1.1
- Operating income ex specials q3 eur m
- 545
- Operating income ex specials change pct
- -5
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.